NM_133642.5:c.1483T>C
Variant names:
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_133642.5(LARGE1):āc.1483T>Cā(p.Trp495Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,609,284 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 33)
Exomes š: 6.9e-7 ( 0 hom. )
Consequence
LARGE1
NM_133642.5 missense
NM_133642.5 missense
Scores
13
4
1
Clinical Significance
Conservation
PhyloP100: 8.67
Publications
4 publications found
Genes affected
LARGE1 (HGNC:6511): (LARGE xylosyl- and glucuronyltransferase 1) This gene encodes a member of the N-acetylglucosaminyltransferase gene family. It encodes a glycosyltransferase which participates in glycosylation of alpha-dystroglycan, and may carry out the synthesis of glycoprotein and glycosphingolipid sugar chains. It may also be involved in the addition of a repeated disaccharide unit. The protein encoded by this gene is the glycotransferase that adds the final xylose and glucuronic acid to alpha-dystroglycan and thereby allows alpha-dystroglycan to bind ligands including laminin 211 and neurexin. Mutations in this gene cause several forms of congenital muscular dystrophy characterized by cognitive disability and abnormal glycosylation of alpha-dystroglycan. Alternative splicing of this gene results in multiple transcript variants that encode the same protein. [provided by RefSeq, May 2018]
LARGE1 Gene-Disease associations (from GenCC):
- muscular dystrophy-dystroglycanopathy type B6Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- congenital muscular dystrophy with intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.984
PP5
Variant 22-33304476-A-G is Pathogenic according to our data. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr22-33304476-A-G is described in CliVar as Pathogenic. Clinvar id is 6219.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
152198
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1457086Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 724226 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
1457086
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
724226
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33378
American (AMR)
AF:
AC:
0
AN:
44264
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26040
East Asian (EAS)
AF:
AC:
0
AN:
39568
South Asian (SAS)
AF:
AC:
0
AN:
85874
European-Finnish (FIN)
AF:
AC:
0
AN:
52966
Middle Eastern (MID)
AF:
AC:
0
AN:
5298
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1109556
Other (OTH)
AF:
AC:
0
AN:
60142
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74346 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
152198
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74346
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41464
American (AMR)
AF:
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68034
Other (OTH)
AF:
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 Pathogenic:1
May 26, 2009
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
.;.;D;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Uncertain
D
PhyloP100
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
.;.;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
.;.;D;D;D
Sift4G
Pathogenic
D;D;D;D;D
Polyphen
1.0
.;.;D;D;D
Vest4
1.0, 1.0, 1.0
MutPred
0.87
.;.;Loss of catalytic residue at P498 (P = 0.0252);Loss of catalytic residue at P498 (P = 0.0252);.;
MVP
MPC
1.9
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.